HUMAN RETROVIRUSES, CANCER AND AIDS: APPROACHES TO PREVENTION AND THERAPY NLM AIDSLINE Important note: Information in this article was accurate in 1988. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


HUMAN RETROVIRUSES, CANCER AND AIDS: APPROACHES TO PREVENTION AND THERAPY

J Cell Biochem; (Suppl 11D):27-75 1987. Unique Identifier : AIDSLINE ICDB/88641435
Anonymous; No affiliation given


Abstract: Abstracts of papers concerned with approaches to prevention and therapy of diseases involving human retroviruses, of cancer, and of AIDS, presented in nine plenary and three poster sessions at a UCLA Symposium, held on April 1-6, 1987, in Keystone, CO, are published in this journal. Headings for the plenary sessions and numbers of abstracts published for each session were as follows: keynote address (1); new retroviruses in man and sub-human primates (2); the HTLV genomes and their products (4); mechanism of virus pathogenesis (2); expression of viral genes in bacteria, yeast, and mammalian cells (3); progress in development of antiviral vaccines (3); workshop on HIV virus, its receptor and target cells (2); progress in design of antiviral agents (4); and clinical trials (1). Headings for the poster sessions and numbers of abstracts published for each session were as follows: new retroviruses--HTLV genomes (25), pathogenesis--viral gene expression in exogenous cells (43), and antiviral strategies and clinical trials (27). Late additions consisted of eight abstracts.
Keywords: Acquired Immunodeficiency Syndrome/DRUG THERAPY/IMMUNOLOGY/ *MICROBIOLOGY Animal Antiviral Agents/THERAPEUTIC USE Congresses Cytopathogenic Effect, Viral *Genes, Viral Human HIV/IMMUNOLOGY Neoplasms/*MICROBIOLOGY *Retroviridae/GENETICS/IMMUNOLOGY/PATHOGENICITY CONGRESS MONOGRAPH

KWDacquiredimmunodeficiencysyndrome/drugtherapy/immunology/KWDmicrobiologyanimalantiviralagents/therapeuticusecongressescytopathogeniceffect,viralKWDgenes,viralhumanhiv/immunologyneoplasms/KWDmicrobiologyKWDretroviridae/genetics/immunology/pathogenicitycongressmonograph
880530
M8850483


Copyright © 1988 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1988. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1988. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .